New appointment brings in key leadership expertise to strengthen its European business
OFFENBACH MAIN, Germany, May 26 /PRNewswire/ -- SIRO ClinPharm Pvt. Ltd., a leading multinational full service Contract Research Organization (CRO), today announced the appointment of Scott L. Spector as President Strategic Operations Europe. Mr. Spector will be based in the Offenbach, Germany office of Omega Mediation.
Mr. Spector brings to Omega Mediation more than 15 years of international CRO experience. Prior to joining Omega Mediation, Mr. Spector served as Chief Executive Officer of AAI Oncology & General Manager of AAI Pharma France which is an oncology focused multinational Contract Research Organization headquartered in Paris, France. Mr. Spector was responsible for the strategic direction of the oncology operations, business development and clinical operations.
"We are delighted to have someone of Scott's caliber on board," said Dr. Chetan Tamhankar, Chief Operating Officer, SIRO Group. "This move is in alignment with our strategy and is bound to give an impetus to our international capabilities. Scott's leadership will contribute substantially to our efforts in becoming a fully-integrated global leader in the provision of clinical research services."
Sofia Hofmann, President Europe said, "Scott's senior management and leadership experience in the European CRO sector will be a valuable asset in pursuing our growth objectives and expansion plans for the business. I am confident he will bring in valuable business insights and help identify future growth opportunities."
"Joining Omega Mediation at this stage in its transformation to a multinational CRO is a tremendous opportunity," said Mr. Spector. "I look forward to working with Dr. Tamhankar and Mrs. Hofmann and the team to execute on our strategy to grow the organization and build shareholder value.
|SOURCE SIRO ClinPharm|
Copyright©2009 PR Newswire.
All rights reserved